Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Overview of attention for article published in JACC, August 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 94 X users

Citations

dimensions_citation: 73 Dimensions

Readers on

mendeley: 96 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Non-ST Elevation ACS: No CV Benefit With Pretreatment Oral P2Y12 Inhibitors

Physician's Weekly, 22 Nov 2021

Pretreatment associated with increased bleeding…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.